OverviewChartNewsTraderScreen

Morgan Stanley Knock-Out BMRN/  DE000MG3BQV1  /

Stuttgart
6/18/2024  9:52:09 PM Chg.- Bid8:07:41 AM Ask8:07:41 AM Underlying Strike price Expiration date Option type
0.570EUR - 0.560
Bid Size: 750		 0.620
Ask Size: 750		 BioMarin Pharmaceuti... 90.1002 USD 12/31/2078 Put
GlobeNewswire 6/13 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...
GlobeNewswire 6/5 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BridgeBio Pharma...
GlobeNewswire 5/28 Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors
GlobeNewswire 5/8 Terns Pharmaceuticals Announces Leadership Changes
GlobeNewswire 11/2/2023 California Life Sciences announces 20th annual Pantheon Award winners
GlobeNewswire 10/2/2023 California’s top scientific innovators selected as finalists for the 20th annual California Life Sci...
GlobeNewswire 3/1/2022 Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Recent Corpor...
GlobeNewswire 2/14/2022 Vaxart Appoints Edward Berg as Senior Vice President and General Counsel
Newsfile Corp 2/4/2022 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.
GlobeNewswire 1/24/2022 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioMarin Pharmaceutical Inc.
GlobeNewswire 12/23/2021 Lifshitz Law Firm, P.C. Announces Investigations of Amarin Corporation plc (NASDAQGM: AMRN), BioMari...
GlobeNewswire 12/21/2021 BMRN FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioMarin Pharmaceutical Inc....
GlobeNewswire 12/20/2021 BMRN & RECAF – Upcoming Lead Deadlines: Bronstein, Gewirtz & Grossman, LLC
GlobeNewswire 12/20/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...
GlobeNewswire 12/17/2021 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losses to Secure C...
GlobeNewswire 12/7/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...
GlobeNewswire 12/7/2021 ROSEN, A LEADING LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors to Secure Counsel Befor...
GlobeNewswire 12/1/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMar...
GlobeNewswire 11/30/2021 AMRN, BMRN & RECAF – Upcoming Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC
GlobeNewswire 11/28/2021 ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Losse...
GlobeNewswire 11/19/2021 AMRN, BMRN & RECAF – Class Actions Deadlines: Bronstein, Gewirtz & Grossman, LLC
GlobeNewswire 11/15/2021 Autolus Therapeutics announces the appointment of Dr. William D. Young as a Non-Executive Director
GlobeNewswire 11/13/2021 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioMarin Pharmaceutical Inc. Investors with Lo...
GlobeNewswire 11/12/2021 AMRN, BMRN & RECAF – Class Action Alerts: Bronstein, Gewirtz & Grossman, LLC
GlobeNewswire 11/10/2021 INVESTOR REMINDER: BIOMARIN PHARMACEUTICAL INC. (NASDAQ: BMRN) SHAREHOLDER CLASS ACTION DEADLINE- Be...